Avivo Biomedical - Crunchbase Company Profile & Funding

Q: Who invested in Avivo Biomedical?

Avivo Biomedical has 3 investors including Genome British Columbia And Innovate BC.

Q: When was the last funding round for Avivo Biomedical?

Avivo Biomedical closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Avivo Biomedical raised to date?

Avivo Biomedical has raised obfuscated.

Overview

Avivo Biomedical

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Avivo Biomedical

CB Rank

58021

Avivo Biomedical operates as a preclinical-stage company.

Founded

obfuscation

Private

Seed

Vancouver, British Columbia, Canada

1-10

avivobio.com/

Biotechnology

Medical

Funding Rounds

Seed

OBF

obfuscation

Grant

OBF

obfuscation

Pre-Seed

OBF

obfuscation

Key People

John Coleman: President and CEO
Past Role: Anandia Labs, COO and Founder
Geoff Houlton: President & CEO

Details

Legal Name

ABOzymes Biomedical Inc.

Also Known As

ABOzymes, ABOzymes Biomedical

Operating Status

Active

Company Type

For Profit

Founders

Geoff Houlton, John Barclay

About the Company

Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Ex Vivo Enzymatic Blood Type Conversion

A process that enzymatically converts donor blood or organs from one blood type to a universal blood type to increase compatibility for transfusions and transplants.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avivo Biomedical	—	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Genome British Columbia	Yes	Grant - Avivo Biomedical	Federica Di Palma
Genome British Columbia	Yes	Grant - Avivo Biomedical	Federica Di Palma
Genome British Columbia	Yes	Grant - Avivo Biomedical	Federica Di Palma
Genome British Columbia	Yes	Grant - Avivo Biomedical	Federica Di Palma
Genome British Columbia	Yes	Grant - Avivo Biomedical	Federica Di Palma